Design and Synthesis of Cytotoxic Compounds by Targeting Cancer Metabolism

dc.contributor.authorHossain, Mohammad
dc.date.accessioned2026-10-28T17:35:47Z
dc.date.available2026-10-28T17:35:47Z
dc.date.issued2026-10-26
dc.description.abstractApart from the well-known properties of malignant cells such as abnormal proliferation, deregulation of apoptosis, and cell cycle, it has now been well established that cancer cells use an altered metabolism compared to normal cells. In fact, cancer cells undergo metabolic re-programming to meet increased energetic and anabolic needs, including those for ATP, reduced coenzymes (e.g., NADPH), lipids, proteins, and nucleotides. Therefore, therapies targeting the metabolic differences between cancers and normal cells have long been a principal strategy for developing novel anticancer drugs for cancer treatment. In this presentation, the synthesis and anticancer properties of three series of novel anticancer compounds will be discussed, which have been designed based on the metabolic differences between cancers and normal cells.
dc.identifier.urihttps://hdl.handle.net/2022/38623
dc.language.isoen_US
dc.rightsThis work may be protected by copyright unless otherwise stated.
dc.subjectCancer metabolism
dc.subjectCytotoxic compounds
dc.subjectAnticancer drug development
dc.subjectMedicinal chemistry
dc.subjectChemical synthesis
dc.subjecthiol alkylation
dc.subjectApoptosis
dc.subjectTumor selectivity
dc.titleDesign and Synthesis of Cytotoxic Compounds by Targeting Cancer Metabolism
dc.typePresentation

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Presentation_Hossain_2026.pdf
Size:
3.1 MB
Format:
Adobe Portable Document Format
Can’t use the file because of accessibility barriers? Contact us